Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transnasal Insufflation for Patients With COPD GOLD IV and Hypercapnia

NCT01090544 is registered in ClinicalTrials.gov with Helios Klinik Ambrock as lead sponsor.

NCT NCT01090544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01090544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transnasal Insufflation for Patients With COPD GOLD IV and Hypercapnia
Lead sponsor
Helios Klinik Ambrock
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2010
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)